Literature DB >> 15737536

Microencapsulation peptide and protein drugs delivery system.

Chuanyun Dai1, Bochu Wang, Hongwei Zhao.   

Abstract

Many methods were used to devise peptide and protein drugs delivery system (DDS). Because of their relatively large size, they have low transdermal bioavailabilities. In systemic delivery of proteins, biodegradable material as parenteral depot formulation occupy an important place because of several aspects like protection of sensitive proteins from degradation, prolonged or modified release, pulsatile release patterns. The main objective in developing controlled release protein injectables is avoidance of regular invasive doses which in turn provide patient compliance, comfort as well as control over blood levels. This review article presents the outstanding contributions in field of microencapsulation as protein delivery systems and different approaches of protein delivery are described. Then discusses how these advances may be applied to resolve the challenges face the development of microcapsule for the controllable delivery of protein drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15737536     DOI: 10.1016/j.colsurfb.2004.10.032

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  16 in total

1.  One-step electrohydrodynamic production of drug-loaded micro- and nanoparticles.

Authors:  Marjan Enayati; Zeeshan Ahmad; Eleanor Stride; Mohan Edirisinghe
Journal:  J R Soc Interface       Date:  2009-10-14       Impact factor: 4.118

2.  Proton Oriented-"Smart Depot" for Responsive Release of Ca2+ to Inhibit Peptide Acylation in PLGA Microspheres.

Authors:  Jiwei Liu; Yan Xu; Yonglu Wang; Hao Ren; Zhengjie Meng; Kuntang Liu; Zhe Liu; He Huang; Xueming Li
Journal:  Pharm Res       Date:  2019-06-04       Impact factor: 4.200

3.  Functionalized bridged silsesquioxane-based nanostructured microspheres: ultrasound-assisted synthesis and in vitro cytotoxicity characterization.

Authors:  Hernán E Romeo; Mónica Cameo; María V Choren; María A Fanovich
Journal:  J Mater Sci Mater Med       Date:  2011-03-19       Impact factor: 3.896

Review 4.  Future of human Chlamydia vaccine: potential of self-adjuvanting biodegradable nanoparticles as safe vaccine delivery vehicles.

Authors:  Rajnish Sahu; Richa Verma; Saurabh Dixit; Joseph U Igietseme; Carolyn M Black; Skyla Duncan; Shree R Singh; Vida A Dennis
Journal:  Expert Rev Vaccines       Date:  2018-02-06       Impact factor: 5.217

5.  Development of enteric submicron particle formulation of papain for oral delivery.

Authors:  Manu Sharma; Vinay Sharma; Amulya K Panda; Dipak K Majumdar
Journal:  Int J Nanomedicine       Date:  2011-09-23

6.  Tumor growth inhibition by mSTEAP peptide nanovaccine inducing augmented CD8+ T cell immune responses.

Authors:  Qiuqiang Chen; Ying Bao; Danielle Burner; Sharmeela Kaushal; Yu Zhang; Theresa Mendoza; Michael Bouvet; Cengiz Ozkan; Boris Minev; Wenxue Ma
Journal:  Drug Deliv Transl Res       Date:  2019-12       Impact factor: 5.671

7.  Formulation, characterization, and expression of a recombinant MOMP Chlamydia trachomatis DNA vaccine encapsulated in chitosan nanoparticles.

Authors:  Chino D Cambridge; Shree R Singh; Alain B Waffo; Stacie J Fairley; Vida A Dennis
Journal:  Int J Nanomedicine       Date:  2013-05-10

8.  A novel pulsed drug-delivery system: polyelectrolyte layer-by-layer coating of chitosan-alginate microgels.

Authors:  Guichen Zhou; Ying Lu; He Zhang; Yan Chen; Yuan Yu; Jing Gao; Duxin Sun; Guoqing Zhang; Hao Zou; Yanqiang Zhong
Journal:  Int J Nanomedicine       Date:  2013-02-28

9.  Controlled release behaviour of protein-loaded microparticles prepared via coaxial or emulsion electrospray.

Authors:  Ying Wang; Xiaoping Yang; Wentao Liu; Feng Zhang; Qing Cai; Xuliang Deng
Journal:  J Microencapsul       Date:  2013-01-25       Impact factor: 3.142

10.  Polymeric microspheres as protein transduction reagents.

Authors:  David Nagel; Jonathan M Behrendt; Gwen F Chimonides; Elizabeth E Torr; Andrew Devitt; Andrew J Sutherland; Anna V Hine
Journal:  Mol Cell Proteomics       Date:  2014-04-01       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.